Home » Health »

Why FDA’s approval of genetic therapy is such a big deal

 

October 12, 2017, 7:32 PM|
On Thursday, an FDA advisory panel gave the green light for a therapy that could improve the vision of people who have a rare genetic disorder called Leber’s congenital amaurosis (LCA). CBS News medical contributor Dr. Tara Narula weighs in.

 

Related Posts

  • No Related Posts